Skip to main content

Table 3 Relative odds of post-anti-thymocyte globulin febrile complications according to procalcitonin concentration on transplantation day

From: Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study

  Quartile of procalcitonin concentration
(range, μg/L)
  Q1
(<1.6)
Q2
(1.6–4.1)
Q3
(4.1–14.9)
Q4
(>183)
P trend
Crude matched pairs      
   OR 1.00 1.10 1.05 1.10 0.095
   95% CI - 0.03–0.85 0.25–5.87 2.51–59.87  
   P value - 0.26 0.11 0.09  
Adjusted for C-reactive protein      
   OR 1.0 1.08 1.10 1.07 0.123
   95% CI - 0.026–0.99 0.31–5.75 2.41–58.35  
   P value - 0.34 0.10 0.09  
  1. The relative odds of post-anti-thymocyte globulin (ATG) febrile/infectious complications did not increase significantly with each increasing quartile of baseline procalcitonin concentration, so patients in the highest versus lowest quartile did not have any increase in risk. After adjustment for C-reactive protein, the concentration of procalcitonin remained unassociated with the risk of post-ATG febrile complications. CI, confidence interval; OR, odds ratio.